For: | Feng YJ, Li YY, Lin XH, Li K, Cao MH. Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK. World J Gastroenterol 2016; 22(43): 9515-9524 [PMID: 27920472 DOI: 10.3748/wjg.v22.i43.9515] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i43/9515.htm |
Number | Citing Articles |
1 |
Marco Gentili, Simona Ronchetti, Erika Ricci, Rosanna Di Paola, Enrico Gugliandolo, Salvatore Cuzzocrea, Oxana Bereshchenko, Graziella Migliorati, Carlo Riccardi. Selective CB2 inverse agonist JTE907 drives T cell differentiation towards a Treg cell phenotype and ameliorates inflammation in a mouse model of inflammatory bowel disease. Pharmacological Research 2019; 141: 21 doi: 10.1016/j.phrs.2018.12.005
|
2 |
Soo Hyun Kim, Mi-Rae Shin, Ah Reum Lee, Bu-Il Seo, Hae-Jin Park, Seong-Soo Roh. Improvement of Inflammation through Antioxidant Pathway of Gardeniae Fructus 50% EtOH Extract (GE) from Acute Reflux Esophagitis Rats. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/4826176
|
3 |
Tim Ambrose, Alison Simmons. Cannabis, Cannabinoids, and the Endocannabinoid System—Is there Therapeutic Potential for Inflammatory Bowel Disease?. Journal of Crohn's and Colitis 2019; 13(4): 525 doi: 10.1093/ecco-jcc/jjy185
|
4 |
Yuchen Song, Haixia Yuan, Tianyi Chen, Manqi Lu, Shuang Lei, Xinmin Han. An Shen Ding Zhi Ling Alleviates Symptoms of Attention Deficit Hyperactivity Disorder via Anti-Inflammatory Effects in Spontaneous Hypertensive Rats. Frontiers in Pharmacology 2021; 11 doi: 10.3389/fphar.2020.617581
|
5 |
Mi-Rae Shin, Hae-Jin Park, Bu-Il Seo, Seong-Soo Roh. New approach of medicinal herbs and sulfasalazine mixture on ulcerative colitis induced by dextran sodium sulfate. World Journal of Gastroenterology 2020; 26(35): 5272-5286 doi: 10.3748/wjg.v26.i35.5272
|
6 |
Lorenza González-Mariscal, Arturo Raya-Sandino, Laura González-González, Christian Hernández-Guzmán. Relationship between G proteins coupled receptors and tight junctions. Tissue Barriers 2018; 6(1): e1414015 doi: 10.1080/21688370.2017.1414015
|
7 |
Magdalena Grill, Christoph Högenauer, Andreas Blesl, Johannes Haybaeck, Nicole Golob-Schwarzl, Nerea Ferreirós, Dominique Thomas, Robert Gurke, Martin Trötzmüller, Harald C. Köfeler, Birgit Gallé, Rudolf Schicho. Members of the endocannabinoid system are distinctly regulated in inflammatory bowel disease and colorectal cancer. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-38865-4
|
8 |
Viktoriia Cherkasova, Olga Kovalchuk, Igor Kovalchuk. Cannabinoids and Endocannabinoid System Changes in Intestinal Inflammation and Colorectal Cancer. Cancers 2021; 13(17): 4353 doi: 10.3390/cancers13174353
|
9 |
Daniel G Couch, Henry Maudslay, Brett Doleman, Jonathan N Lund, Saoirse E O’Sullivan. The Use of Cannabinoids in Colitis: A Systematic Review and Meta-Analysis. Inflammatory Bowel Diseases 2018; 24(4): 680 doi: 10.1093/ibd/izy014
|
10 |
Luiz Guilherme H. S. Aragão, Júlia T. Oliveira, Jairo R. Temerozo, Mayara A. Mendes, José Alexandre Salerno, Carolina S. G. Pedrosa, Teresa Puig-Pijuan, Carla P. Veríssimo, Isis M. Ornelas, Thayana Torquato, Gabriela Vitória, Carolina Q. Sacramento, Natalia Fintelman-Rodrigues, Suelen da Silva Gomes Dias, Vinicius Cardoso Soares, Letícia R. Q. Souza, Karina Karmirian, Livia Goto-Silva, Diogo Biagi, Estela M. Cruvinel, Rafael Dariolli, Daniel R. Furtado, Patrícia T. Bozza, Helena L. Borges, Thiago M. L. Souza, Marília Zaluar P. Guimarães, Stevens K. Rehen. WIN 55,212-2 shows anti-inflammatory and survival properties in human iPSC-derived cardiomyocytes infected with SARS-CoV-2. PeerJ 2021; 9: e12262 doi: 10.7717/peerj.12262
|
11 |
Min-zheng Zhu, Mei-feng Yang, Yang Song, Hao-ming Xu, Jing Xu, Ning-ning Yue, Yuan Zhang, Cheng-mei Tian, Rui-yue Shi, Yu-jie Liang, Jun Yao, Li-sheng Wang, Yu-qiang Nie, De-feng Li. Exploring the efficacy of herbal medicinal products as oral therapy for inflammatory bowel disease. Biomedicine & Pharmacotherapy 2023; 165: 115266 doi: 10.1016/j.biopha.2023.115266
|
12 |
Walaa H. El-Maadawy, Ehab Hafiz, Hend Okasha, Noha A. Osman, Gamila H. Ali, Rehab Ali Hussein. Phycocyanin stimulates ulcerative colitis healing via selective activation of cannabinoid receptor-2, intestinal mucosal healing, Treg accumulation, and p38MAPK/MK2 signaling inhibition. Life Sciences 2022; 305: 120741 doi: 10.1016/j.lfs.2022.120741
|
13 |
Laís M. S. Neves, Elaine C. D. Gonçalves, Juliana Cavalli, Graziela Vieira, Larissa R. Laurindo, Róli R. Simões, Igor S. Coelho, Adair R. S. Santos, Alexandre M. Marcolino, Maíra Cola, Rafael C. Dutra. Photobiomodulation Therapy Improves Acute Inflammatory Response in Mice: the Role of Cannabinoid Receptors/ATP-Sensitive K+ Channel/p38-MAPK Signalling Pathway. Molecular Neurobiology 2018; 55(7): 5580 doi: 10.1007/s12035-017-0792-z
|
14 |
Mengjuan Lin, Lei Chen, Yong Xiao, Baoping Yu. Activation of cannabinoid 2 receptor relieves colonic hypermotility in a rat model of irritable bowel syndrome. Neurogastroenterology & Motility 2019; 31(6) doi: 10.1111/nmo.13555
|
15 |
Dingya Sun, Xin Li, Shengdan Nie, Jiajia Liu, Shan Wang. Disorders of cancer metabolism: The therapeutic potential of cannabinoids. Biomedicine & Pharmacotherapy 2023; 157: 113993 doi: 10.1016/j.biopha.2022.113993
|
16 |
Newman Osafo, Oduro K. Yeboah, Aaron O. Antwi. Endocannabinoid system and its modulation of brain, gut, joint and skin inflammation. Molecular Biology Reports 2021; 48(4): 3665 doi: 10.1007/s11033-021-06366-1
|
17 |
Priscila A. Lima, Bárbara B. Berg, Marina Gomes Miranda e Castor. Involvement of the cannabinoid system in chronic inflammatory intestinal diseases: opportunities for new therapies. Intestinal Research 2022; 20(4): 392 doi: 10.5217/ir.2021.00160
|
18 |
Yunna Lee, Yuju Kim, Soyeong Park, Gwangbeom Heo, Hae Young Chung, Eunok Im. Cannabinoid receptor type 1 in the aging gut regulates the mucosal permeability via miR-191-5p. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1241097
|
19 |
Rui Liang, Wei Chen, Huining Fan, Xiaoyu Chen, Jing Zhang, Jin-Shui Zhu. Dihydroartemisinin prevents dextran sodium sulphate-induced colitis through inhibition of the activation of NLRP3 inflammasome and p38 MAPK signaling. International Immunopharmacology 2020; 88: 106949 doi: 10.1016/j.intimp.2020.106949
|
20 |
Astrid Coronado-Álvarez, Karen Romero-Cordero, Lorena Macías-Triana, Agnes Tatum-Kuri, Alba Vera-Barrón, Henning Budde, Sérgio Machado, Tetsuya Yamamoto, Claudio Imperatori, Eric Murillo-Rodríguez. The synthetic CB1 cannabinoid receptor selective agonists: Putative medical uses and their legalization. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2021; 110: 110301 doi: 10.1016/j.pnpbp.2021.110301
|
21 |
Thamilarasan Manivasagam, Arokiasamy Justin-Thenmozhi, M. Walid Qoronfleh, Asokan Prema. Proteins Associated with Neurodevelopmental Disorders. Nutritional Neurosciences 2022; : 205 doi: 10.1007/978-981-15-9781-7_7
|
22 |
Amin Malek, Sara Ahmadi Badi, Gilda Karimi, Tania Bizouarn, Saeed Irian, Seyed Davar Siadat. The effect of Bacteroides fragilis and its postbiotics on the expression of genes involved in the endocannabinoid system and intestinal epithelial integrity in Caco-2 cells. Journal of Diabetes & Metabolic Disorders 2023; 22(2): 1417 doi: 10.1007/s40200-023-01264-8
|
23 |
Grainne Holleran, Franco Scaldaferri, Antonio Gasbarrini, Diego Currò. Herbal medicinal products for inflammatory bowel disease: A focus on those assessed in double‐blind randomised controlled trials. Phytotherapy Research 2020; 34(1): 77 doi: 10.1002/ptr.6517
|
24 |
Sonia Kiran, Ahmed Rakib, Bob M. Moore, Udai P. Singh. Cannabinoid Receptor 2 (CB2) Inverse Agonist SMM-189 Induces Expression of Endogenous CB2 and Protein Kinase A That Differentially Modulates the Immune Response and Suppresses Experimental Colitis. Pharmaceutics 2022; 14(5): 936 doi: 10.3390/pharmaceutics14050936
|
25 |
Ronald J Ellis, Scott Peterson, Mariana Cherner, Erin Morgan, Rachel Schrier, Bin Tang, Martin Hoenigl, Scott Letendre, Jenny Iudicello. Beneficial Effects of Cannabis on Blood–Brain Barrier Function in Human Immunodeficiency Virus. Clinical Infectious Diseases 2021; 73(1): 124 doi: 10.1093/cid/ciaa437
|